Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial
<p>Neuroinflammation has been proposed to impact symptomatology in patients with schizophrenia spectrum disorders. While previous studies have shown equivocal effects of treatments with add-on anti-inflammatory drugs such as Aspirin, <i>N</i>-acetylcysteine and Celecoxib, none have...
Main Authors: | Strube, W, Aksar, A, Bauer, I, Barbosa, S, Benros, M, Blankenstein, C, Campana, M, Davidovic, L, Glaichenhaus, N, Falkai, P, Görlitz, T, Hansbauer, M, Heilig, D, Khalfallah, O, Leboyer, M, Martinuzzi, E, Mayer, S, Moussiopoulou, J, Papazova, I, Perić, N, Wagner, E, Schneider-Axmann, T, Simon, J, Hasan, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer
2022
|
Similar Items
-
Efficacy of celecoxib add-on treatment for immuno-metabolic depression: Protocol of the INFLAMED double-blind placebo-controlled randomized controlled trial
by: J.C. Zwiep, et al.
Published: (2023-02-01) -
Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
by: MacDonald, TM, et al.
Published: (2016) -
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2009) -
Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Adam Gędek, et al.
Published: (2023-05-01) -
A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer.
by: Sooriakumaran, P, et al.
Published: (2006)